Hyderabad, India-headquartered Dr. Reddy's Laboratories Ltd.'s wholly owned subsidiary, Dr. Reddy's Laboratories SA, announced the acquisition of the U.S. generic prescription product portfolio of Australia-based Mayne Pharma Group Limited. The U.S. generic prescription portfolio includes approximately 45 commercial products, four pipeline products, and 40 approved non-marketed products, including a number...